Here are the biggest calls on Wall Street on Monday: Citi initiates Dutch Bros as buy Citi says the coffee chain has the "energy" to growth. "We believe BROS has proven its portability across the US, and, beyond a multi-year 'brand funnel' tailwind (driven by footprint expansion and a fast-growing marketing budget), other key SSS levers are set to layer into the story in the coming 12-24 months." Read more. Goldman Sachs reiterates Tesla as neutral Goldman says it's concerned about too much competition in the self-driving space. "While we continue to believe that Tesla will grow its [full self-driving] and robotaxi operations and business over time, we also expect competition to gate the degree of profit growth." JPMorgan initiates Compass as overweight JPMorgan called the company a "tech-enabled leader" in real estate. "We initiate coverage of Compass (COMP) with an Overweight rating and a December 2026 price target of $15." JPMorgan initiates Exponent as overweight JPMorgan says it sees a "strong rebound" for the industrial company. "We initiate coverage of Exponent (EXPO) with an Overweight rating and a Dec-26 price target of $100, representing ~35% upside potential. EXPO is a leader in science and engineering consulting, serving over 2,000 clients across 17 primary practices." KeyBanc upgrades Solventum to overweight from sector weight KeyBanc says it's bullish on the health-care company's spinoff from 3M. "We continue to believe SOLV' s spin from 3M is off to an encouraging start and, since our initiation, have grown incrementally positive around its progression toward LT targets." Needham upgrades AppLovin to buy from hold Neeham says investors should buy the dip. "We upgrade APP to Buy and establish a $700 PT following additional work on ecommerce giving us more confidence in the trajectory of ecommerce revenue growth in '26E coming at the same time the stock has pulled back off the highs a month ago." UBS reiterates Nvidia as buy UBS says it's sticking with shares of Nvidia. "Conversations on NVDA revolve mostly around the existential question of what will get the stock moving again – we still believe investors underappreciate how strong demand is and believe NVDA's backlog may now extend well into 2027 with a sizable portion of C2027 now already booked out." JPMorgan reiterates Apple as overweight JPMorgan raised its price target to $315 per share from $305 ahead of earnings later this week. "However, we see a positive set up for the shares heading into F1Q26 (Dec-end) earnings print as AAPL shares are trading at 30x NTM [next twelve months] P/E, below the peak multiple that is typical for the shares heading into a key iPhone product cycle in combination with the modest upsides in relation to both F1Q26 print and the F2Q26 outlook." Read more . Rothschild & Co Redburn upgrades Meta to buy from neutral The firm called Meta the "best demand machine in the world." "With imminent FY26 guidance set to leave estimates factoring in all the cost and little upside from AI, now seems opportune for investors to start building positions. We therefore upgrade to Buy, lifting our price target (PT) to $900 from $740." Read more. Morgan Stanley upgrades Corpay to overweight from equal weight Morgan Stanley says it sees a "see a path for sustained mid- to high-teens EPS growth with stablecoin fears overblown" for the corporate payments financial company. "We are upgrading Corpay to Overweight with a $379 PT as we see a path for sustained mid-teens EPS growth and overblown stablecoin fears amid early signs of the long-awaited recovery in freight / trucking demand." Deutsche Bank upgrades Cognizant Technology Solutions to buy from hold Deutsche says the IT services stock is a "bright spot in a tough sector." "We are upgrading CTSH to Buy as we think the company is positioned to remain in the "Winner's Circle" and continue growing revenue above the industry average." Evercore ISI upgrades Cisco to outperform from in line Evercore says the stock riding plenty of tailwinds. "We are upgrading CSCO to OP rating (from In Line) and adjusting our target to $100 (prior $80). While investors will debate if CSCO is cyclical or secular – our sense is there are plenty of tailwinds to ensure CSCO can sustain high single-digit sales and low-teens EPS growth on a multi-year basis, making it an attractive asset at under 20x P/E vs. large cap tech peers." Bank of America initiates Lazard as buy The firm says investors should "own the turnaround" in the asset management company. "We are initiating coverage of Lazard Inc. (LAZ) with a Buy rating and $65 price objective." Bank of America initiates Evercore as buy The boutique investment bank has upside potential. "We are initiating coverage on Evercore Inc . (EVR) with a Buy rating and $435 price objective, implying 20% upside potential." Bank of America initiates Belite Bio as buy Bank of America says it's bullish on the pediatric eye disease company. "We initiate coverage of Belite Bio ( BLTE) with a Buy rating and $195 PO. BLTE is developing the potential first-approved therapy for Stargardt disease type 1 (STGD1), a rare genetic disease leading to loss in vison in children." Goldman Sachs reiterates Microsoft as buy The firm says investors should buy Microsoft stock ahead of earnings later this week. "We believe risk/reward is skewed positive into the print." BTIG initiates Freddie Mac as buy BTIG says it's bullish on the government mortgage company. "We're initiating coverage of Freddie Mac (FMCC) with a Buy rating and a $20 price target."
